The COVID-19 pandemic has raised profound ethical challenges on an unprecedented global scale. These challenges include how to allocate scarce resources (especially vaccines and therapeutics), both within and between countries, whether and when to mandate vaccines and/or masks, whether and how to co
...
nduct public health surveillance, whether to issue vaccine passports, and how to address stark international and intranational inequities. In addition, there have been ethical concerns about the conduct of COVID-19 research, such as the appropriateness of challenge studies.
more
Research
BMJ 2014;349:g4643 doi: 10.1136/bmj.g4643 (Published 5 August 2014), 1-11
These guidelines have been developed for scientific purpose with the main aim to guide the regulatory authority for evaluating probiotic products in our country.
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-neg
...
ative tuberculosis (SHINE Study)
more
Full document available: https://www.icmr.nic.in/sites/default/files/guidelines/Gastric%20Cancer%20Final%20pdf%20for%20farrow_0.pdf | Prepared as an outcome of ICMR Subcommittee on Gastric Cancer | Coordinated by Division
...
of Non Communicable Diseases | This Consensus Document on Management of Gastric Cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also interweaves clinical, biochemical and epidemiological studies.
more
F.No. INDO/FRC/442/2008-IHD | INDIAN COUNCIL OF MEDICAL
...
RESEARCH
| New Delhi, the 1st July, 2014 | OFFICE MEMORANDUM
more
SOP number: ICMR-NIV/2019-nCoV/Specimens_01
Prepared by: Dr. Y.K. Gurav Reviewed by: Dr. V. Potdar Approved by: Dr. P. Abraham
Date: 19/01/2020 Date: 20/01/2020 Date: 20/01/2020
Norman Bhagwan, New Dehli
Dated 21st March, 2020
The results of the SHINE trial have been published in the NEJM today. SHINE looked at whether treatment for children with minimal TB could be reduced from 6 months to 4 months. It found that the four month treatment was as good as the standard six m
...
onths treatment for children with minimal TB
more
Page visited January 2019, publication date unknown.
Republic of India (hereinafter the Recipient) willimplement the Covid-19 Emergency Response and Health Systems Preparedness project (the Project), with the involvement of the following Ministries/Ag
...
encies/Units: Ministry of Health and Family Welfare (MoHFW), Indian Council of Medical Research (ICMR) and the National Center for Disease Control (NCDC).The International Bank for Reconstruction and Development (hereinafter the Bank) has agreed to provide financingfor the Project.
more
Manual on Hospital Infection Control Guidelines prepared by the Indian Council of Medical
...
Research Antimicrobial Stewardship Program. The document covers the basic principles of infection control, role of heath care workers, bio-waste management and elaborates on the steps to be followed for setting up of an effective infection control in hospitals.
more
COVAXINTM, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of
...
Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) high containment facility.
The vaccine received DCGI approval for Phase I & II Human Clinical Trials and the trials commenced across India from July, 2020.
After successful completion of the interim analysis from the Phase 1 & 2 clinical trials of COVAXINTM, Bharat Biotech received DCGI approval for Phase 3 clinical trials in 26,000 participants in over 25 centres across India.
more
Indian Hypertension Control Initiative (IHCI) is a 5-year initiative involving the Ministry of Health & Family Welfare, Indian
...
Council of Medical Research, State Governments, and WHO-India.
more